Skip to content

Repetitive transcranial magnetic stimulation for tinnitus treatment

Effects of repetitive Transcranial Magnetic Stimulation on chronic tinnitus

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-748nrs
Enrollment
Unknown
Registered
2018-05-25
Start date
2017-02-03
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tinnitus

Interventions

All patients will will undergo a complete otorrhynolaringological visit, tonal and vocal audiometry and imitanciometry. Patients will answer the tinnitus handicap inventiry, beck depression and anxiet
Procedure/surgery
E02.621.820

Sponsors

Instituto de Psiquiatria Universidade Federal do Rio de Janeiro
Lead Sponsor
Instituto de Psiquiatria Universidade Federal do Rio de Janeiro
Collaborator

Eligibility

Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age between 18 and 75 years of age. Presence of tinnitus between 6 months and 5 years. Moderate to catastrophic annoyance with tinnitus measured by the Tinnitus Handicap Inventory. Normal hearing test or sensorineural hearing loss compatible with age.

Exclusion criteria

Exclusion criteria: Objective tinnitus. Incapability to answer the scales and questionnaires. Neurologic or cognitive diseases. External or middle ear disease. Tinnitus with specific treament of the basic cause as thyroid hormones, somatossensory tinnitus. Use of pacemakers or metallic components in the head and neck region. Pregnancy

Design outcomes

Primary

MeasureTime frame
Tinnitus Handicap Inventory reduction higher than 7 points

Secondary

MeasureTime frame
Tinnitus loudness and minimal masking level reduction higher than 3 dB and visual analog scale reduction higher than 3 points

Countries

Brazil

Contacts

Public ContactPatricia Linhares Pinto

Instituto de Psiquiatria Universidade Federal do Rio de Janeiro

patriciaciminelli@gmail.com+55 21 99233-4888

Outcome results

None listed

Source: REBEC (via WHO ICTRP)